Table 4.
FVF (n = 8) | True anterograde AP (n= 14) | p-value | |
---|---|---|---|
Age at preexcitation diagnosis (years) | 15.0 (1.7–17.2) | 11.6 (0.5–16.7) | 0.172 |
Age at HCM diagnosis (years) | 14.1 (0.3–19.3) | 12.5 (0.3–16.7) | 0.633 |
Male sex | 4 (50) | 8 (57) | 1.000 |
PR interval (ms) | 103 (80–125) | 95 (65–145) | 0.560 |
QRS duration (ms) | 115 (96–125) | 113 (95–192) | 0.946 |
DWA 40 ms after delta onset (mm) | 4.1 (3.3–15.3) | 4.9 (1.1–22.5) | 0.838 |
Average QRS amplitude (mm) | 29.9 (14.4–47.0) | 31.4 (10.6–79.9) | 0.811 |
V6 R-wave amplitude (mm) | 30.6 (12.8–39.3) | 28.1 (11.4–65.0) | 0.918 |
Normalized V6 R-wave amplitude | 1.2 (0.5–1.6) | 1.1 (0.4–2.5) | 0.891 |
V1 S-wave amplitude (mm) | 22.6 (5.9–41.8) | 27.0 (0.0–75.3) | 0.891 |
Normalized V1 S-wave amplitude | 1.1 (0.2–2.0) | 1.1 (0.0–3.1) | 0.946 |
Storage disease | 3 (38) | 5 (26) | 1.000 |
Metabolic disease | 1 (13) | 2 (14) | 1.000 |
Syndromic | 0 (0) | 2 (14) | 0.491 |
Isolated HCM | 4 (50) | 5 (38) | ref |
Supraventricular tachycardia | 0 (0) | 5 (36) | 0.115 |
Atrial fibrillation | 3 (38) | 3 (21) | 0.624 |
data expressed as n (%) or median (range)
HCM = hypertrophic cardiomyopathy, DWA = delta wave amplitude, FVF = fasciculoventricular fiber, AP = accessory pathway